Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Ono Pharmaceutical Co., Ltd.    4528   JP3197600004

ONO PHARMACEUTICAL CO., LTD.

(4528)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Ono Pharmaceutical Co., Ltd. : annual earnings release

share with twitter share with LinkedIn share with facebook
05/07/2020 | 09:15am EDT

The company will report its earnings for FY 2020 on 05/12/2020. Generally, the company reports earnings better than estimates. In recent months, the 13 analysts from Standard & Poor's consensus have revised their EPS estimates downward.

Stocks mentioned in the article
ChangeLast1st jan.
ONO PHARMACEUTICAL CO., LTD. -0.76% 3014 End-of-day quote.20.46%
THE NEW HOME COMPANY INC. 6.17% 3.27 Delayed Quote.-33.91%

© MarketScreener.com 2020
share with twitter share with LinkedIn share with facebook
Latest news on ONO PHARMACEUTICAL CO., LT
07/07ONO PHARMACEUTICAL : Notice regarding Filing an Appeal for a Lawsuit against the..
AQ
07/06ONO PHARMACEUTICAL : Notice Concerning Determination of Details of Issuance of S..
AQ
06/30ONO PHARMACEUTICAL : Receives a Manufacturing and Marketing Approval in Japan of..
AQ
06/30ONO PHARMACEUTICAL : A Short-Acting Selective 1 Blocker, Onoact for Intravenous ..
AQ
06/19ONO PHARMACEUTICAL : Nobel laureate Honjo sues Ono Pharmaceutical over patent ro..
AQ
06/12ONO PHARMACEUTICAL : and Seikagaku Announce the Results from a Phase III Clinica..
AQ
06/08ONO PHARMACEUTICAL : Joins RE100, an International Initiative Aiming to Use 100%..
AQ
06/08BRISTOL MYERS SQUIBB : Ono Pharmaceutical Co., Ltd. - Opdivo Intravenous Infusio..
AQ
06/08ONO PHARMACEUTICAL : FOIPAN Tablets, a Protease Enzyme Inhibitor, ONO Has Starte..
AQ
05/13ONO PHARMACEUTICAL : establishes a specified subsidiary and a local subsidiary i..
AQ
More news
Financials
Sales 2021 308 B 2 874 M 2 874 M
Net income 2021 65 100 M 606 M 606 M
Net cash 2021 106 B 986 M 986 M
P/E ratio 2021 23,4x
Yield 2021 1,61%
Capitalization 1 504 B 13 997 M 14 013 M
EV / Sales 2020
EV / Sales 2021 4,53x
Nbr of Employees 3 560
Free-Float 75,6%
Chart ONO PHARMACEUTICAL CO., LTD.
Duration : Period :
Ono Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONO PHARMACEUTICAL CO., LT
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 3 151,54 JPY
Last Close Price 3 014,00 JPY
Spread / Highest target 23,4%
Spread / Average Target 4,56%
Spread / Lowest Target -18,7%
EPS Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Toichi Takino Managing Executive Officer & GM-Research
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director & Executive Vice President
Isao Ono Director & Managing Executive Officer